Smith & Nephew plc has grown revenue 5.7% a year over three years and 6.2% a year over five, with earnings per share compounding at 41%. Revenue growth, 3-year annual rate: +5.7% (Medical Devices median +12%). Revenue growth, 5-year rate: +6.2%, growth has slowed since the five-year average. Earnings per share, 3-year rate: +41%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 11, FY2015 to FY2025, as filed.

SNNSmith & Nephew plc

Healthcare

$27.24-24% 1Y

$27.24

$26.4352 weeks$36.61

Is it growing?

Good

Growing: earnings up +52% year on year and operating margin widening (+1.5 points).

2 good, 1 neutral

Revenue trend+6% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +6% a year.

Earnings trend+52% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction+1.5 points operating

Trailing-twelve-month operating margin, 12.9% now against 11.4% a year earlier.

All from SEC EDGAR, as of Dec 31, 2025.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is SNN growing?

Smith & Nephew plc has grown revenue 5.7% a year over three years and 6.2% a year over five, with earnings per share compounding at 41%.

+5.7%

Revenue growth, 3-year annual rate · Medical Devices median +12% · steady growth, ahead of inflation · compounded from fiscal years as filed

Revenue growth, 5-year rate: +6.2%
Revenue growth, 5-year rate · +5.7% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: +41%
Earnings per share, 3-year rate · revenue +5.7% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 11
Years of annual history on file · FY2015 to FY2025, as filed